




Searching News Database: Paladin Labs
HSMN NewsFeed - 13 Nov 2014
Nuvo Research(R) reacquires Pennsaid(R) 2% rights to South America, Central America, South Africa and Israel
Nuvo Research(R) reacquires Pennsaid(R) 2% rights to South America, Central America, South Africa and Israel
HSMN NewsFeed - 11 Aug 2014
Auxilium Pharmaceuticals, Inc. Appoints Andrew Saik Chief Financial Officer
Auxilium Pharmaceuticals, Inc. Appoints Andrew Saik Chief Financial Officer
HSMN NewsFeed - 18 Nov 2013
Auxilium Announces Results of the XIAFLEX(R) in Dupuytren's MULTICORD Contracture Trial
Auxilium Announces Results of the XIAFLEX(R) in Dupuytren's MULTICORD Contracture Trial
HSMN NewsFeed - 5 Feb 2013
Somaxon Pharmaceuticals Announces Settlement of Silenor Patent Litigation With Actavis
Somaxon Pharmaceuticals Announces Settlement of Silenor Patent Litigation With Actavis
HSMN NewsFeed - 5 Sep 2012
Auxilium Pharmaceuticals, Inc. Announces 30 Month XIAFLEX(R) Safety Update
Auxilium Pharmaceuticals, Inc. Announces 30 Month XIAFLEX(R) Safety Update
HSMN NewsFeed - 19 Jul 2012
Somaxon Pharmaceuticals Announces Settlement of Silenor Patent Litigation With Zydus
Somaxon Pharmaceuticals Announces Settlement of Silenor Patent Litigation With Zydus
HSMN NewsFeed - 8 Dec 2011
Auxilium Pharmaceuticals, Inc. Appoints Adrian Adams Chief Executive Officer and President
Auxilium Pharmaceuticals, Inc. Appoints Adrian Adams Chief Executive Officer and President
HSMN NewsFeed - 7 Sep 2011
Auxilium Pharmaceuticals, Inc. Announces Positive Top-Line Results from XIAFLEX(R) Multi-Cord Study
Auxilium Pharmaceuticals, Inc. Announces Positive Top-Line Results from XIAFLEX(R) Multi-Cord Study
HSMN NewsFeed - 6 Sep 2011
Auxilium Pharmaceuticals, Inc. Announces 17 Month XIAFLEX(R) Safety Update
Auxilium Pharmaceuticals, Inc. Announces 17 Month XIAFLEX(R) Safety Update
HSMN NewsFeed - 17 Aug 2011
Labopharm Inc. Enters Into an Agreement to Be Acquired by Paladin Labs Inc.
Labopharm Inc. Enters Into an Agreement to Be Acquired by Paladin Labs Inc.
HSMN NewsFeed - 8 Aug 2011
Auxilium Pharmaceuticals, Inc. Announces Promotion of Dr. James P. Tursi to Chief Medical Officer
Auxilium Pharmaceuticals, Inc. Announces Promotion of Dr. James P. Tursi to Chief Medical Officer
HSMN NewsFeed - 11 Apr 2011
Auxilium Pharmaceuticals, Inc. Announces Launch of XIAPEX(R) in EU by Pfizer
Auxilium Pharmaceuticals, Inc. Announces Launch of XIAPEX(R) in EU by Pfizer
HSMN NewsFeed - 7 May 2009
Paladin Labs and Isotechnika Inc. Form Partnership for Commercialization of Voclosporin
Paladin Labs and Isotechnika Inc. Form Partnership for Commercialization of Voclosporin
HSMN NewsFeed - 3 Mar 2008
AEterna Zentaris and Paladin Labs Announce Sale and Purchase of Miltefosine Rights
AEterna Zentaris and Paladin Labs Announce Sale and Purchase of Miltefosine Rights
HSMN NewsFeed - 18 Feb 2008
Paladin Labs & KV Pharmaceuticals Sign Distribution For Micro-K(R) Extencaps(R) Capsules
Paladin Labs & KV Pharmaceuticals Sign Distribution For Micro-K(R) Extencaps(R) Capsules
HSMN NewsFeed - 1 Feb 2008
Canadian Marketing and Sales Effort for Labopharm's Once-Daily Tramadol Product to Expand Significantly
Canadian Marketing and Sales Effort for Labopharm's Once-Daily Tramadol Product to Expand Significantly
HSMN NewsFeed - 17 Sep 2007
Paladin and Labopharm Launch Tridural(TM) Once-Daily Tramadol Product in Canada
Paladin and Labopharm Launch Tridural(TM) Once-Daily Tramadol Product in Canada
HSMN NewsFeed - 9 Aug 2007
Paladin And Glide Pharma Sign Exclusive Agreement for Novel Needle-Free Drug Delivery System
Paladin And Glide Pharma Sign Exclusive Agreement for Novel Needle-Free Drug Delivery System
HSMN NewsFeed - 8 Aug 2007
Paladin Expands Distribution Agreement with Shire HGT to Include ELAPRASE(TM) (Idursulfase)
Paladin Expands Distribution Agreement with Shire HGT to Include ELAPRASE(TM) (Idursulfase)
HSMN NewsFeed - 12 Dec 2006
Auxilium Pharmaceuticals, Inc. Announces Distribution Agreement With Paladin Labs for Testim(R) in Canada
Auxilium Pharmaceuticals, Inc. Announces Distribution Agreement With Paladin Labs for Testim(R) in Canada
HSMN NewsFeed - 14 Mar 2006
Valera Pharmaceuticals Announces Paladin Labs Receives Canadian Approval of VANTAS
Valera Pharmaceuticals Announces Paladin Labs Receives Canadian Approval of VANTAS
HSMN NewsFeed - 14 Mar 2006
Health Canada Approves Vantas'R' for the Treatment of Advanced Prostate Cancer
Health Canada Approves Vantas'R' for the Treatment of Advanced Prostate Cancer
Additional items found! 22

Members Archive contains
22 additional stories matching:
Paladin Labs
(Password required)
Paladin Labs
(Password required)